spacer image  spacer image  spacer image
 spacer image
 spacer image
 spacer image
 spacer image
 spacer image
 spacer image
 spacer image
 spacer image
 spacer image
Industries
 spacer image
 spacer image
 spacer image
 spacer image
 spacer image
 spacer image
 spacer image
 spacer image
 spacer image
 spacer image
 spacer image
 spacer image
 spacer image
 spacer image
Fenwick & West LLP  spacer image
 search image SEARCH
 
Fenwick & West Home HOME
Contact Us CONTACT US
 pixel spacer image
spacer
1/4/2012 spacer Doctors Fear Copyright Crackdown on Medical Procedures
   
Mitchell Zimmerman, Chair of the Copyright Group at Fenwick & West, was recently quoted in the San Francisco Examiner article "Doctors Fear Copyright Crackdown on Medical Problems."... more
spacer
11/3/2011 spacer Prometheus – Unbound or Not
   
Michael Shuster, co-chair of the Life Sciences Group with Fenwick & West, was recently quoted in the Drug Discovery News article "Prometheus – Unbound or Not."... more
spacer
10/28/2011 spacer Fenwick & West Wins M&A Deal of the Year Awards
   
Fenwick & West LLP is pleased to announce that the firm was honored with two awards by the Global M&A Network – “North America M&A Deal of the Year (Upper Mid Markets)” and “U.S. M&A Deal of the Year (Large Market)”. ... more
spacer
10/27/2011 spacer Fenwick & West Helps Client Novozymes Win Patent Infringement Case
   
Fenwick & West LLP is pleased to announce that on October 24 and 26, 2011, a federal jury sitting in the United States District Court for the Western District of Wisconsin returned unanimous verdicts in favor of the firm's clients Novozymes ... more
spacer
8/17/2011 spacer Fenwick & West's Silicon Valley Venture Capital Survey Reveals Strong Valuations in Second Quarter of 2011
Barometer Valuation Result Highest Since 2007
   
Fenwick & West LLP, one of the nation's premier law firms providing comprehensive legal services to high technology and life science clients, today announced the results of its Second Quarter 2011 Silicon Valley ... more
spacer
8/10/2011 spacer Two Fenwick & West Partners Named as Top Biotech Lawyers for 2011
   
Fenwick & West congratulates Gordon Davidson, Firm Chairman and Partner in the Corporate ... more
spacer
5/26/2011 spacer Fenwick & West Chairman Elected to BayBio Board of Directors
   
Fenwick & West LLP is pleased to announce that firm chairman and corporate partner Gordon K. Davidson has been elected to the BayBio Board of Directors. ... more
spacer
4/11/2011 spacer Fenwick & West Partners with Rock Health for Health Care Technology Incubation Program
   
Fenwick & West LLP, a leading technology and life sciences law firm, is pleased to announce its partnership with Rock Health and its new incubator program linking developers and entrepreneurs with the most innovative minds in health and technology.... more
spacer
4/11/2011 spacer The Economy in Silicon Valley
   
Mark Stevens, Co-Chair of the Private Equity Group and Partner in the Corporate and Intellectual Property Groups of Fenwick & West, was featured in the KLIV 1590 Silicon Valley News radio program, The Economy in Silicon Valley.... more
spacer
12/27/2010 spacer Fenwick & West Client CardioDx’s Blood Test Named As One of TIME Magazine’s Top Ten Medical Breakthroughs of 2010
   
TIME Magazine named CardioDx’s blood-based gene expression test, Corus™ CAD, one of the Top Ten medical breakthroughs of 2010. The Corus CAD test also won a Technology Innovation Award from The Wall Street Journal this year.... more
spacer
11/1/2010 spacer Extranets Cut Costs in Law Departments
   
Matt Kesner, Chief Technology Officer, and Michael Sands, a partner and co-chair of the more
spacer
10/22/2010 spacer Legal Help Has Arrived for the Cash-Strapped Entrepreneur
   
Ted Wang, a partner in the Corporate Group of Fenwick & West, was recently featured in the ... more
spacer
10/21/2010 spacer Fenwick Client Synosia Therapeutics Enters into a Collaboration and Receives Funding from UCB
   
Fenwick & West LLP congratulates client Synosia Therapeutics on its recently announced collaboration and investment round with UCB Pharma. Fenwick has provided Synosia with strategic and comprehensive ... more
spacer
10/8/2010 spacer Fenwick Represents Joule Unlimited in Patent Issuance on Renewable Diesel Production from Sunlight and CO2
   
Fenwick & West LLP represented its client Joule Unlimited, Inc., pioneer of Liquid Fuel from the Sun™, in securing a U.S. patent to protect its breakthrough conversion of sunlight and waste ... more
spacer
9/20/2010 spacer Fenwick & West Represents Asthmatx in Acquisition by Boston Scientific
   
Fenwick & West LLP represented Sunnyvale, CA-based Asthmatx, Inc., developer of a catheter-based outpatient procedure that provides long lasting and improved asthma control for adult severe asthma patients, in its recently announced acquisition by Boston Scientific Corporation (NYSE: BSX).... more
spacer
8/17/2010 spacer Fenwick & West Represents Axolotl in Acquisition by Ingenix
   
Fenwick & West LLP represented its client Axolotl, a leading provider of health information exchange (HIE) solutions for states, communities, hospitals and health systems, in its recently announced acquisition by Eden Prairie, MN-based Ingenix, a leading provider of health information, technology and consulting services to over 240,000 physicians and nearly 6,000 hospitals. Financial terms of the acquisition were not disclosed. ... more
spacer
5/27/2010 spacer Fenwick & West Represents SonoSite in Acquisition of Visualsonics
   
Fenwick & West LLP represented SonoSite, Inc., the world leader and specialist in bedside and point-of-care ultrasound, in its recently announced acquisition of Visualsonics... more
spacer
4/29/2010 spacer Patenting Nature and Seattle Biotech
   
Andrew T. Serafini, Ph.D., and IP partner in the Life Sciences Group at Fenwick & West LLP, was recently featured on the National Public Radio KUOW segment "Patenting Nature and Seattle Biotech."... more
spacer
3/1/2010 spacer Fenwick & West Adds Prominent IP Litigation Partner in Seattle
   
Fenwick & West LLP, a leading technology and life sciences law firm with offices in Seattle, Silicon Valley and San Francisco, is pleased to announce today that prominent Seattle-based patent litigation lawyer, David K. Tellekson, ... more
spacer
1/21/2010 spacer Fenwick & West Represents DexCom in $35M Follow-on Offering
   
Fenwick & West LLP represented DexCom, Inc. (Nasdaq: DXCM), a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems, in its $35 million follow-on public offering... more
spacer
1/12/2010 spacer Fenwick & West Represents ZymoGenetics in $96.6 Million Follow-on Offering
   
Fenwick & West LLP represented ZymoGenetics, Inc. (NASDAQ: ZGEN), a biopharmaceutical company focused on the development and commercialization of therapeutic proteins, in a $96.6 million follow-on public offering ... more
spacer
12/9/2009 spacer PTO Pilot Program To Speed Up Some Green-Tech Patent Applications
   
Stuart Meyer, partner in the Intellectual Property Group at Fenwick & West LLP, was recently quoted in the National Law Journal article, "PTO Pilot Program To Speed Up Some Green-Tech Patent Applications."... more
spacer
10/16/2009 spacer Fenwick & West Files Ariad v. Eli Lilly Amicus Brief on Behalf of Eight Universities
   
Fenwick & West LLP yesterday filed an amicus brief with the Federal Circuit on behalf of the country's leading research institutions, including The Regents of the University of California... more
spacer
9/1/2009 spacer Doctoring The Lilly Doctrine
   
Michael Shuster, Ph.D., partner in the Intellectual Property Group and Co-Chair of the Life Sciences Group at Fenwick & West LLP, was recently quoted in the BioCentury article, "Doctoring The Lilly Doctrine."... more
spacer
7/1/2009 spacer Technology Transfer Considerations for Stem Cell Technologies
   
Andrew T. Serafini, Ph.D., Partner in the Intellectual Property Group at Fenwick & West LLP, and Melissa Harwood, Patent Agent in the Intellectual Property Group at Fenwick & West LLP, were published in the ... more
spacer
5/21/2009 spacer Patents for Human Genes Face Legal Challenge
   
Fenwick & West Partner Dr. Michael Shuster was quoted in a MedPage Today article titled "Patents for Human Genes Face Legal Challenge."... more
spacer
4/8/2009 spacer Michael Shuster Named One of California's Top IP Portfolio Managers
   
Fenwick & West congratulates Michael Shuster, Intellectual Property Partner and Co-Chair of the firm's Life Sciences Group, for being named one of the Top 25 Leading Portfolio Managers ... more
spacer
4/6/2009 spacer Gilead’s Hypertension Drug Darusentan Will Likely Receive Patent Extension, Attorneys Say
   
Narinder Banait was recently quoted in the Pharmawire article, "Gilead's Hypertension Drug Darusentan Will Likely Receive Patent Extension, Attorneys Say."... more
spacer
3/2/2009 spacer Fenwick & West's Silicon Valley Venture Capital Survey Reveals Valuations Weakening in Fourth Quarter of 2008
   
Fenwick & West LLP today announced results of its Fourth Quarter 2008 Silicon Valley Venture Capital Survey... more
spacer
2/17/2009 spacer M&A Activity Likely to Heat Up in Stem Cell Space Following Reversal on Federal Funding, Experts Say
   
Narinder Banait, a partner in the Life Sciences Group with Fenwick & West, was recently quoted in the Pharmawire article, "M&A Activity Likely to Heat ... more
spacer
2/11/2009 spacer Fenwick & West Represents DexCom in $48M Public Offering
   
Fenwick & West recently represented client DexCom, Inc. (Nasdaq: DXCM) in its $48 million offering of 15,844,000 shares of its common stock ... more
spacer
12/11/2008 spacer Fenwick & West Congratulates Monogram Biosciences on Biotech Patent Portfolio Ranking
   
Fenwick & West congratulates its client Monogram Biosciences on placing 21st in the most recent Wall Street Journal Biotech Industry Patent Scorecard for biotech portfolios.... more
spacer
11/10/2008 spacer Green IP: A Thorny Challenge
   
Fenwick & West partner Michael Shuster is quoted in the November 2008 ... more
spacer
6/17/2008 spacer Fenwick & West Represents LipoSonix in Acquisition by Medicis
   
Fenwick & West LLP represented Bothell, WA-based LipoSonix, Inc. in its recently announced acquisition by Medicis (NYSE: MRX)... more
spacer
5/28/2008 spacer Fenwick & West Represents Becton in Acquisition of Cytopeia
   
Fenwick & West LLP represented Becton, Dickinson and Company (NYSE: BDX) in its recently announced acquisition of Seattle, WA-based Cytopeia Inc.... more
spacer
4/14/2008 spacer Thriving Seattle Tech and Life Sciences Sector Draws National Law Firms to Washington
   
Fenwick & West LLP was recently spotlighted in a National Law Journal article entitled, "Thriving Seattle Tech Sector Draws Law Firms." Stephen Graham, Managing Partner of the firm's Seattle ... more
spacer
4/14/2008 spacer Fenwick & West Continues to Grow its Seattle Office Rapidly; Adds IP Partner Andrew Serafini To Continue Expansion of Life Sciences Practice
   
Fenwick & West LLP announced today the addition of Andrew T. Serafini, Ph.D., as a partner in its firmwide intellectual property group. ... more
spacer
3/20/2008 spacer Fenwick & West SF Bay Area Life Sciences Venture Capital Survey Reveals 45% Increase in Valuations
   
Fenwick & West San Francisco Bay Area Life Sciences Venture Capital Survey Reveals 45% Increase in Valuations... more
spacer
3/5/2008 spacer Fenwick & West's San Francisco Bay Area Venture Capital Survey Shows Continued Improvement in Valuations in Fourth Quarter of 2007
   
Up Rounds Exceed Down Rounds for 16th Consecutive Quarter... more
spacer
2/7/2008 spacer Fenwick & West Adds Three Prominent Corporate Partners in Seattle;
Expands Life Sciences Practice
   
Fenwick & West LLP announced today that three prominent Seattle corporate lawyers, Stephen M. Graham, Roger M. Tolbert and Alan C. Smith, have joined the firm and will launch its Seattle office.... more
spacer
1/8/2008 spacer Fenwick & West's San Francisco Bay Area Venture Capital Survey Reveals 79% Increase in Valuations in 3rd Quarter of 2007
   
Increase in Valuations is Largest Since Survey Began... more
spacer
12/26/2007 spacer Fenwick & West Elects Six New Partners
   
Fenwick & West LLP announced that it has elected six associates to join the Firm's partnership, effective January 1, 2008... more
spacer
9/10/2007 spacer Digital Dialogue Revs Up at Top Firms
   
Matt Kesner, Fenwick & West's Chief Technology Officer, was recently interviewed by Legal Technology News about the use of online collaboration, wireless tools and technical support teams at top law firms. ... more
spacer
9/1/2007 spacer VC Funding Trends for Life Science Firms
   
Rob Dellenbach, a corporate partner at Fenwick & West, analyzes the number and value of venture capital investments in the healthcare, medical device and biopharmaceutical sectors... more
spacer
3/28/2007 spacer Fenwick & West's Third Annual San Francisco Bay Area Life Sciences Venture Capital Survey Reveals 50
   
Results Show a Continuation of the Positive Trend in the Life Science Venture Environment... more
spacer
3/28/2007 spacer Fenwick & West’s Third Annual San Francisco Bay Area Life Sciences Venture Capital Survey
   
Results Show a Continuation of the Positive Trend in the Life Science Venture Environment... more
spacer
10/23/2006 spacer Fenwick & West Represents Connetics in $930 Million Merger with Stiefel Laboratories
   
Fenwick & West LLP represented Connetics Corporation in its recently announced merger with Stiefel Laboratories, Inc., the world's largest independent pharmaceutical company specializing in dermatology.... more
spacer
9/25/2006 spacer Schwarz Jumps Into Pharma Consolidation Trend
   
Sergio Garcia, co-chairman of Fenwick & West's Life Sciences Group was recently quoted in a Forbes article... more
spacer
8/4/2006 spacer Ariad v Lilly, Part II: The next big patent battle
   
The pharmaceutical industry is paying close attention to an upcoming legal show down, slated for August 7, between Ariad Pharmaceuticals and Eli Lilly & Co. A U.S. District Court jury in May ... more
spacer
7/23/2006 spacer Pharmaceutical Giants View Biotech Players as Key to the Future
   
Sergio Garcia, co-chairman of Fenwick & West’s Life Sciences Group was recently quoted in an Oakland Tribune article... more
spacer
7/21/2006 spacer Stem Cells: From DC to CA
   
Michael J. Shuster, Ph.D., co-chair of the firm's Life Sciences Group was recently interviewed by Lisa Krieger, life science and biotech reporter with the San Jose Mercury News... more
spacer
4/12/2006 spacer Partnerships Drive Biotech Boom
   
Sergio Garcia, co-chair of the Life Sciences practice group at Fenwick & West, was quoted in The Recorder’s front page article on the increase in partnership and collaboration deals ... more
spacer
12/16/2005 spacer Fenwick & West Represents Kleiner Perkins and Texas Pacific Group in Investment in Publicly-Traded Life Sciences Company
   
Fenwick & West LLP represented investors Kleiner Perkins Caufield & Byers and Texas Pacific Group in their recently announced investment in BioCryst Pharmaceuticals (NASDAQ: BCRX)... more
spacer